N-甲基-N-戊基乙酰胺 | 4164-91-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-甲基-N-戊基乙酰胺
• 中文别名: 苯乙酸,-α--[(2,2-二甲基-1-羰基丙基)甲基氨基]-
• 英文名称: Methylpentylacetamide
• 英文别名: N-methyl-N-pentylacetamide
• CAS: 4164-91-4
• 化学式: C₈H₁₇NO
• 分子量: 143.23
• InChiKey: SJDKCSDRXBBRKQ-UHFFFAOYSA-N

物化性质

• 沸点：
  261.35°C (rough estimate)
• 密度：
  0.9636 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2924199090

文献信息

• Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
  申请人：——

  公开号：US20030092757A1

  公开（公告）日：2003-05-15

  Disclosed herein is a method for favorably modulating the health-related quality of life and the health-related quality-adjusted time-to-disease progression in a patient having prostate cancer and a method for measuring of the health-related quality-adjusted time-to-disease progression.

  本文揭示了一种有利地调节患有前列腺癌患者的健康相关生活质量和健康相关质量调整的疾病进展时间的方法，以及一种测量健康相关质量调整的疾病进展时间的方法。
• [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof
  申请人：Masuda Akira

  公开号：US20070010515A1

  公开（公告）日：2007-01-11

  Novel [1,2,4]triazolo[1,5-a]pyrimidine derivative of the general formula (1): (1) its prodrug or a pharmaceutically acceptable salt thereof, which exhibits an antigen presentation inhibiting activity and is useful as a preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease and also useful as an anticancer drug or as an immunological tolerance inducer for transplanted organ/transplanted bone marrow.

  这是一种通式为(1)的[1,2,4]三唑并[1,5-a]嘧啶衍生物的小说，其中(1)是其前药或其药学上可接受的盐，具有抗原呈递抑制活性，可用作预防和/或治疗器官/骨髓移植、自身免疫性疾病、过敏性疾病和/或炎症性疾病的免疫排斥和/或移植物抗宿主反应的预防和/或治疗剂，同时也可用作抗癌药物或用于移植器官/移植骨髓的免疫耐受诱导剂。
• 1,5-NAPHTHYRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME
  申请人：Onco Therapy Science, Inc.

  公开号：US20150005302A1

  公开（公告）日：2015-01-01

  The present invention directs a compound represented by formula (I).

  本发明涉及一种由式(I)所表示的化合物。
• A system for delivering hydrophobic liquid bleach activators
  申请人：THE PROCTER & GAMBLE COMPANY

  公开号：EP0859047A2

  公开（公告）日：1998-08-19

  The present invention relates to a system for delivering liquid bleach activators to solid or granular peroxygen bleach containing compositions. The preferred delivery system is liquid activators complexed with a cyclodextrin, preferably beta-cyclodextrin. The present invention also relates to a method for preparing the liquid bleach activator/cyclodextrin complexes described herein.

  本发明涉及一种向固体或颗粒状含过氧漂白剂组合物输送液体漂白活化剂的系统。优选的输送系统是与环糊精（最好是β-环糊精）络合的液体活化剂。本发明还涉及一种制备所述液体漂白活化剂/环糊精复合物的方法。
• [1,2,4 ]TRIAZOLO [1,5-A]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：EP1630165A1

  公开（公告）日：2006-03-01

  Novel [1,2,4]triazolo[1,5-a]pyrimidine derivative of the general formula (1): (1) its prodrug or a pharmaceutically acceptable salt thereof, which exhibits an antigen presentation inhibiting activity and is useful as a preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease and also useful as an anticancer drug or as an immunological tolerance inducer for transplanted organ/transplanted bone marrow.

  通式（1）的新型[1,2,4]三唑并[1,5-a]嘧啶衍生物：(1) 其原药或其药学上可接受的盐，具有抗原递呈抑制活性，可作为器官/骨髓移植、自身免疫性疾病、过敏性疾病和/或炎症性疾病中免疫排斥和/或移植物与宿主反应的预防和/或治疗药物，也可作为抗癌药物或移植器官/移植骨髓的免疫耐受诱导剂。